As the NF1-mutant melanomas often harbor a high mutation load [14, 15], we reasoned that genetic or epigenetic alterations affecting genes other than p53 and Cdkn2a are likely required in combination with NF1-loss to initiate melanoma transformation in vivo. This evidence concerns the gene CDKN2A and melanoma.